Yazan Alsayed, MD | |
1545 Airport Blvd, Suite 2000, Pensacola, FL 32504-8615 | |
(850) 474-8382 | |
(850) 474-8149 |
Full Name | Yazan Alsayed |
---|---|
Gender | Male |
Speciality | Medical Oncology |
Experience | 35 Years |
Location | 1545 Airport Blvd, Pensacola, Florida |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1558460626 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | ME110878 (Florida) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sacred Heart Hospital | Pensacola, FL | Hospital |
Baptist Hospital | Pensacola, FL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Sacred Heart Health System Inc | 3779491386 | 355 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.'s, New Drug Application (NDA) for ZEGERID OTC™ Capsules (omeprazole/sodium bicarbonate) with a dosage strength of 20 mg of omeprazole for over-the-counter (OTC) treatment of frequent heartburn.
In the first study across time into late childhood of the effects of prenatal drug exposure on sleep, prenatal drug exposure is associated with greater sleep problems in children.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has been featured in an in-depth report by Griffin Securities, a New York-based brokerage firm, highlighting the importance of the role that cancer stem cell (CSCs) targeting technology such as that employed by its lead product candidate, ICT-121, may play in developing future cancer treatments.
VitaminSpice has received a revised purchase order that increases the previous $5 million, March 9, 2011 Purchase Order, to $6.94 million. VitaminSpice received the revised PO from West and Associates, Las Vegas.
› Verified 9 days ago
Entity Name | Sacred Heart Health System Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962453308 PECOS PAC ID: 3779491386 Enrollment ID: O20051015000049 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.'s, New Drug Application (NDA) for ZEGERID OTC™ Capsules (omeprazole/sodium bicarbonate) with a dosage strength of 20 mg of omeprazole for over-the-counter (OTC) treatment of frequent heartburn.
In the first study across time into late childhood of the effects of prenatal drug exposure on sleep, prenatal drug exposure is associated with greater sleep problems in children.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has been featured in an in-depth report by Griffin Securities, a New York-based brokerage firm, highlighting the importance of the role that cancer stem cell (CSCs) targeting technology such as that employed by its lead product candidate, ICT-121, may play in developing future cancer treatments.
VitaminSpice has received a revised purchase order that increases the previous $5 million, March 9, 2011 Purchase Order, to $6.94 million. VitaminSpice received the revised PO from West and Associates, Las Vegas.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Yazan Alsayed, MD Po Box 2699, Pensacola, FL 32513-2699 Ph: (850) 474-8382 | Yazan Alsayed, MD 1545 Airport Blvd, Suite 2000, Pensacola, FL 32504-8615 Ph: (850) 474-8382 |
News Archive
Santarus, Inc., a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Schering-Plough HealthCare Products, Inc.'s, New Drug Application (NDA) for ZEGERID OTC™ Capsules (omeprazole/sodium bicarbonate) with a dosage strength of 20 mg of omeprazole for over-the-counter (OTC) treatment of frequent heartburn.
In the first study across time into late childhood of the effects of prenatal drug exposure on sleep, prenatal drug exposure is associated with greater sleep problems in children.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it has been featured in an in-depth report by Griffin Securities, a New York-based brokerage firm, highlighting the importance of the role that cancer stem cell (CSCs) targeting technology such as that employed by its lead product candidate, ICT-121, may play in developing future cancer treatments.
VitaminSpice has received a revised purchase order that increases the previous $5 million, March 9, 2011 Purchase Order, to $6.94 million. VitaminSpice received the revised PO from West and Associates, Las Vegas.
› Verified 9 days ago
Mohamed K Helmi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5149 N. 9th Ave., Suite 120, Pensacola, FL 32504 Phone: 850-477-9253 Fax: 850-494-9843 | |
Dr. Peter A Marco, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5149 N. 9th Avenue, Suite 120, Pensacola, FL 32504 Phone: 850-477-9253 Fax: 850-494-9843 | |
Dr. Paul T Castro, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 8383 N Davis Hwy, West Florida Hospital, Pensacola, FL 32514 Phone: 850-494-5403 Fax: 850-494-4382 | |
Alejandro A Inclan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4724 N Davis Hwy, Pensacola, FL 32503 Phone: 850-696-4000 Fax: 850-444-7057 | |
Dr. Samual Wade Sauer, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4451 Bayou Blvd, Pensacola, FL 32503 Phone: 850-416-7619 Fax: 850-416-7753 | |
Dr. Robert E Bondurant, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10095 Hillview Dr, Pensacola, FL 32514 Phone: 850-479-4000 Fax: 850-479-4034 | |
Dr. Edgar Antonio Gonzalez, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 6000 W Highway 98, Pensacola Naval Hospital, Pensacola, FL 32512 Phone: 850-515-7171 |